ALBIO — Biosynex SA Cashflow Statement
0.000.00%
Last trade - 00:00- €22.12m
- €74.77m
- €101.17m
- 41
- 77
- 31
- 46
Annual cashflow statement for Biosynex SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 31.4 | 107 | 21.2 | -35.6 | -43.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.001 | 0.031 | -0.008 | -0.017 | 0.565 |
| Unusual Items | |||||
| Changes in Working Capital | -7.18 | 0.578 | -37.3 | 14.5 | 12.9 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 31.6 | 110 | 4.95 | -9.65 | -10.1 |
| Capital Expenditures | -9.12 | -19 | -37.8 | -39.5 | -4.84 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1.19 | -9.95 | -9 | -15.3 | 0.244 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -7.93 | -29 | -46.8 | -54.8 | -4.6 |
| Financing Cash Flow Items | 0.154 | -1.78 | -21.2 | 0.808 | 3.29 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10.6 | 14.4 | -10.8 | 5.17 | -0.801 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 34.3 | 95.3 | -52.6 | -59.3 | -15.5 |